Intersect ENT Inc

NASDAQ:XENT  
19.98
+0.34 (+1.73%)
Other Pre-Announcement

Intersect Ent Announces Preliminary Revenue For Second Quarter Of 2021 And Closing Of $60 Million Term Loan

Published: 07/22/2021 20:31 GMT
Intersect ENT Inc (XENT) - Intersect Ent Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan.
Sees FY Revenue $117 Million to $121 Million.
Q2 Revenue $60 Million.
Q2 Revenue Estimate $28 Million -- Refinitiv Ibes Data (analyst estimates).
Reiterates Full Year 2021 Revenue Guidance of $117 Million - $121 Million.
FY2021 Revenue View $119.8 Million -- Refinitiv Ibes Data (analyst estimates).